{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:12:36Z","timestamp":1788545556737,"version":"build-2803163510"},"reference-count":35,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16GRNT27610030"],"award-info":[{"award-number":["16GRNT27610030"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"award":["16GRNT27610030"],"award-info":[{"award-number":["16GRNT27610030"]}],"id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-17-IBS-312"],"award-info":[{"award-number":["1-17-IBS-312"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1-17-IBS-312"],"award-info":[{"award-number":["1-17-IBS-312"]}],"id":[{"id":"https:\/\/ror.org\/04f6cgz95","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670665"],"award-info":[{"award-number":["81670665"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["81670665"],"award-info":[{"award-number":["81670665"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Plasma prorenin is commonly elevated in patients with diabetes and has been associated with the development of albuminuria and progression of diabetic nephropathy. Because albuminuria often reflects podocyte injury, the pathogenic role of prorenin in podocyte dysfunction warrants further investigation. In this study, we examined the association between prorenin and podocyte injury, as well as glomerular fibrosis, using a transgenic rat model in which prorenin is inducibly expressed and secreted from the liver. cyp1a1-prorenin transgenic rats were randomized to receive diets containing increasing concentrations of the gene activator indole-3-carbinol (I3C; 0.05%, 0.15%, or 0.3%) for 4 weeks. Wild-type rats maintained on a normal diet served as controls. I3C administration resulted in a dose-dependent increase in plasma prorenin levels in transgenic rats. Elevated prorenin was associated with increased mean arterial pressure and urinary albumin excretion, accompanied by a dose-dependent reduction in podocyte number and slit diaphragm protein expression, as well as segmental foot process effacement and podocyte hypertrophy. In addition, increased prorenin stimulated renal expression of profibrotic factors and promoted glomerular fibrosis. Treatment with either amlodipine or enalapril for 6 weeks prevented the development of hypertension and partially attenuated podocyte injury, albuminuria, and renal fibrosis, without fully reversing these changes. These protective effects were associated with suppression of NF-\u03baB- and Nox2-mediated inflammatory and oxidative stress pathways. Collectively, these findings demonstrate that prorenin promotes podocyte injury and glomerular fibrosis through mechanisms that are partially dependent on hypertension and angiotensin II but also involve angiotensin II-independent pathways.<\/jats:p>","DOI":"10.3390\/ijms27177888","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:13:25Z","timestamp":1788455605000},"page":"7888","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated Prorenin Induces Podocyte Injury and Glomerular Fibrosis in cyp1a1-Prorenin Transgenic Rats"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-8840","authenticated-orcid":false,"given":"Chunyan","family":"Gu","sequence":"first","affiliation":[{"name":"Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84108, USA"},{"name":"Department of Pathophysiology, College of Medicine, University of Nantong, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-5269","authenticated-orcid":false,"given":"Yufeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Nephrology & Hypertension, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM198505303122202","article-title":"Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications","volume":"312","author":"Luetscher","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/bjo.2004.056580","article-title":"Serum prorenin levels and diabetic retinopathy in type 2 diabetes: New method to measure serum level of prorenin using antibody activating direct kinetic assay","volume":"89","author":"Yokota","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM199010183231604","article-title":"Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus","volume":"323","author":"Wilson","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/14.8.1904","article-title":"Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy","volume":"14","author":"Deinum","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004670000514","article-title":"Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes","volume":"16","author":"Chiarelli","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000514302","article-title":"Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort","volume":"52","author":"Cho","year":"2021","journal-title":"Am. J. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.ki.5000265","article-title":"Renin\/prorenin receptors","volume":"69","author":"Nguyen","year":"2006","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.0000251700.00994.0d","article-title":"A novel signal transduction cascade involving direct physical interaction of the renin\/prorenin receptor with the transcription factor promyelocytic zinc finger protein","volume":"99","author":"Schefe","year":"2006","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1042\/CS20171659","article-title":"Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats","volume":"132","author":"Zhou","year":"2018","journal-title":"Clin. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1681\/ASN.2011020202","article-title":"Prorenin receptor is essential for normal podocyte structure and function","volume":"22","author":"Oshima","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2011020200","article-title":"Prorenin receptor is essential for podocyte autophagy and survival","volume":"22","author":"Riediger","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Li, C., and Siragy, H.M. (2014). High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-beta-catenin-snail signaling pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089233"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI21398","article-title":"Inhibition of diabetic nephropathy by a decoy peptide corresponding to the \u201chandle\u201d region for nonproteolytic activation of prorenin","volume":"114","author":"Ichihara","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1681\/ASN.2006010029","article-title":"Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice","volume":"17","author":"Ichihara","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36727","DOI":"10.1074\/jbc.M103296200","article-title":"Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease","volume":"276","author":"Kantachuvesiri","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1242\/jcs.109.11.2619","article-title":"Regulation of the CYP1A1 promoter in transgenic mice: An exquisitely sensitive on-off system for cell specific gene regulation","volume":"109","author":"Campbell","year":"1996","journal-title":"J. Cell Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11926","DOI":"10.1073\/pnas.92.25.11926","article-title":"Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice","volume":"92","author":"Smith","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0735-1097(01)01548-0","article-title":"Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats","volume":"38","author":"Nishikawa","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1046\/j.1523-1755.1998.00164.x","article-title":"Targeting TGF-beta overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade","volume":"54","author":"Peters","year":"1998","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1523-1755.2004.00901.x","article-title":"Combining TGF-\u03b2 inhibition and Angiotensin II blockade results in enhanced anti-fibrotic effect","volume":"66","author":"Yu","year":"2004","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0168-8227(90)90032-O","article-title":"Altered synthesis of renin in patients with insulin-dependent diabetes: Plasma prorenin as a marker predicting the evolution of nephropathy","volume":"10","author":"Amemiya","year":"1990","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-71-4-1008","article-title":"High plasma prorenin in diabetes mellitus and its correlation with some complications","volume":"71","author":"Franken","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hanna, C., Etry, H.E., Ibrahim, M., Khalife, L., Bahous, S.A., and Faour, W.H. (2025). Podocyturia an emerging biomarker for kidney injury. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04039-w"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Peng, H., Li, W., Seth, D.M., Nair, A.R., Francis, J., and Feng, Y. (2013). (Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0058339"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/1440-1681.12813","article-title":"(Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells","volume":"44","author":"Gonzalez","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1210\/en.2009-1368","article-title":"Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways","volume":"151","author":"Huang","year":"2010","journal-title":"Endocrinology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0003-2697(80)90300-0","article-title":"Enzyme-linked immunoassay (ELISA) for connective tissue components","volume":"104","author":"Rennard","year":"1980","journal-title":"Anal. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200318038","article-title":"A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis","volume":"112","author":"Huang","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1470320312466127","article-title":"Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes","volume":"15","author":"Gu","year":"2014","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1113\/expphysiol.2013.077610","article-title":"A PAI-1 mutant retards diabetic nephropathy in db\/db mice through protecting podocytes","volume":"99","author":"Zhang","year":"2014","journal-title":"Exp. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/CS20130223","article-title":"Valsartan slows the progression of diabetic nephropathy in db\/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation","volume":"126","author":"Zhou","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1681\/ASN.2007040510","article-title":"A PAI-1 Mutant, PAI-1R, Slows Progression of Diabetic Nephropathy","volume":"19","author":"Huang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"F723","DOI":"10.1152\/ajprenal.00271.2011","article-title":"Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis","volume":"301","author":"Zhang","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7888\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:26:26Z","timestamp":1788542786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":35,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177888"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177888","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}